Ryan Lathrop

Title: The Innovative Journey of Ryan Lathrop in Pharmaceutical Advancements

Introduction

Ryan Lathrop, an inventive mind from Hazelwood, Missouri, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Lathrop's work focuses on developing innovative solutions that prioritize safety and efficacy in medication delivery systems.

Latest Patents

Lathrop's latest patents revolve around the creation of extended-release, abuse-deterrent dosage forms. These formulations feature crush-resistant controlled-release particles that integrate plastic and elastic polymers, along with active pharmaceutical ingredients (APIs) or their pharmaceutically acceptable salts. These dosage forms are designed to be prepared using a hot melt extrusion process, effectively providing both abuse deterrent properties and controlled release of medications.

Career Highlights

Currently, Ryan Lathrop is affiliated with Specgx LLC, a company dedicated to pharmaceutical innovation. His expertise in creating advanced drug delivery mechanisms highlights his commitment to improving patient outcomes and addressing critical challenges in medicine administration.

Collaborations

Throughout his career, Lathrop has collaborated with talented peers, including Jonathan Gaik and Jaehan Park. These collaborations have fostered an environment of creativity and innovation, driving the development of impactful pharmaceutical solutions together.

Conclusion

With a remarkable focus on developing safer and more effective drug delivery systems, Ryan Lathrop continues to push the boundaries of pharmaceutical research. His patents serve as a testament to his dedication and ingenuity in the field, contributing to a brighter future for medication safety and efficacy.